We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Massachusetts Financial Services
76
Massachusetts Financial Services
Massachusetts
$2.21M -$66.4K -5,800 -3%
Wells Fargo
77
Wells Fargo
California
$2.18M +$878K +76,761 +80%
Squarepoint
78
Squarepoint
New York
$2.12M -$4.25M -371,575 -69%
State of Wisconsin Investment Board
79
State of Wisconsin Investment Board
Wisconsin
$2.12M +$782K +68,374 +68%
DFCM
80
Dark Forest Capital Management
Puerto Rico
$1.99M +$1.81M +157,954 New
OLA
81
Oliver Luxxe Assets
New Jersey
$1.97M +$1.79M +156,488 New
OSAM
82
O'Shaughnessy Asset Management
Connecticut
$1.97M +$90.7K +7,931 +5%
Principal Financial Group
83
Principal Financial Group
Iowa
$1.95M +$531K +46,433 +43%
Los Angeles Capital Management
84
Los Angeles Capital Management
California
$1.95M -$409K -35,733 -16%
California State Teachers Retirement System (CalSTRS)
85
California State Teachers Retirement System (CalSTRS)
California
$1.9M -$1.49K -130 -0.1%
Legal & General Group
86
Legal & General Group
United Kingdom
$1.88M -$171K -14,988 -9%
CIP
87
Convergence Investment Partners
Florida
$1.85M +$567K +49,513 +51%
T. Rowe Price Associates
88
T. Rowe Price Associates
Maryland
$1.82M +$80.3K +7,015 +5%
HF
89
HRT Financial
New York
$1.82M +$1.65M +144,642 New
GC
90
Globeflex Capital
California
$1.72M +$1.19M +104,321 +324%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
91
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.66M – – –
N
92
Numerai
California
$1.57M +$103K +9,035 +8%
AIM
93
Artemis Investment Management
United Kingdom
$1.57M +$1.43M +124,899 New
Deutsche Bank
94
Deutsche Bank
Germany
$1.49M -$9.56M -835,451 -88%
Two Sigma Advisers
95
Two Sigma Advisers
New York
$1.47M +$970K +84,800 +263%
BCM
96
Bridgeway Capital Management
Texas
$1.4M +$1.28M +111,449 New
Rockefeller Capital Management
97
Rockefeller Capital Management
New York
$1.39M +$1.26M +109,959 New
HSBC Holdings
98
HSBC Holdings
United Kingdom
$1.3M +$18K +1,569 +2%
RWM
99
Ritholtz Wealth Management
New York
$1.29M -$8K -699 -0.7%
NSUP
100
NLB Skladi upravljanje premozenja
$1.26M +$1.14M +100,000 New
2 3
4
5 6

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.